GcMAF triggers our immune response to cancer. Cancer cells deactivate Gc-MAF. Dr. Nobuto Yamamoto has shown that laboratory preparation and injections of GcMAF bypasses the cancer’s deactivation process and allows the macrophages to attack. This procedure has resulted in 100 percent cure rates for 4 to 7 years, the length of the studies to date. There are no side effects.